Elhízás: ki dolgozik rajta

Intézményenként egy kártya. Célpontra vagy országra szűkítheted a listát.

• Minden célpont
• GLP-1 172
• PPAR 0
• FTO 0
• AMPK 3
• GIP 20
• SGLT2 5
• STAT3 0
• SIRT1 0
• PI3K 0
• NRF2 0
• AKT 0
• mTOR 2
• NLRP3 3
• MAPK 0
• TP53 0
• TNF 0
• IL-6 1
• TLR4 0
• BDNF 2
• DPP-4 1
• JNK 0
• APOE 0
• ERK 0
• IL-17 1
• PTEN 0
• STING 0
• ACE2 0
• HIF-1 0
• PCSK9 0
• VEGF 0
• IL-1 0
• JAK 0
• PNPLA3 2
• YAP 0
• HMGB1 0
• CTNNB1 0
• HER2 0
• MMP-9 0
• PD-L1 0
• PINK1 0
• TFEB 0
• TREM2 0
• CCR5 0
• FGFR 0
• GPX4 0
• IGF1R 0
• IL-23 0
• METTL3 0
• PD-1 0
• STK11 0
• AR 0
• BCL-2 0
• CFTR 0
• COX-2 0
• HDAC 0
• EGFR 0
• HSP90 0
• MEK 0
• MYC 0
• PKM2 0

1+ intézményből 1, a friss publikációk és a nyitott vizsgálatok szerint rendezve. Ez nem minőségi rangsor.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIAID · F30

  The role of Aiolos in lung-resident CD8+ memory T cell programming.

  Ohio State University· Columbus, Egyesült Államok· 45 821 USD awarded in fiscal year 2026· until 2030. okt.

• NIH NICHD · F32

  Role of the Placental Intrinsic Clock as a Central Regulator of Endocrine Function and Offspring Growth

  University of Minnesota· Minneapolis, Egyesült Államok· 76 300 USD awarded in fiscal year 2026· until 2029. jún.

• NIH NIAID · F31

  Dysregulation of Aging Regulatory T-Cell Response in Autoimmune Disease

  Utah State Higher Education System--University of Utah· Salt Lake City, Egyesült Államok· 38 914 USD awarded in fiscal year 2026· until 2029. okt.

• NIH NIA · R01

  The effects of sleep and diet on glial function

  Texas A&m University· College Station, Egyesült Államok· 527 686 USD awarded in fiscal year 2026· until 2031. máj.

• NIH NIDDK · RC2

  Interorgan Genomic Atlas for Discovery of Bioenergetic Dynamics and Mechanisms of Time-Restricted Feeding

  Northwestern University· Chicago, Egyesült Államok· 1 641 136 USD awarded in fiscal year 2026· until 2031. jún.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Elucidating the role of maternal nutrient stores in the metabolism of the preimplantation embryo (MaterMeta)

  Kobenhavns Universitet· Kobenhavn, Dánia· EU contribution 247 553 EUR· until 2029. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Studying the role of Tbx-3 expressing neurons during obesity and ageing (OBrAgeing)

  Institut National de la Sante Et de la Recherche Medicale· Paris, Franciaország· EU contribution 226 421 EUR· until 2029. aug.

• European Commission (Horizon Europe) · HORIZON-ERC

  Selective Sensory Vagal Interface: a bionic platform for internal organ modulation (VisceraLink)

  Medizinische Universitaet Wien· Wien, Ausztria· EU contribution 2 210 625 EUR· until 2031. dec.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Metabolic disease heterogeneity definition, prevention and remission with targeted interventions (MEDIculous REMeDy)

  Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit und Umwelt Gmbh· Neuherberg, Németország· EU contribution 4 437 236 EUR· until 2030. dec.· 11 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-DN

  Bridging Chronobiology and Physiology through Expert Training (ChronoBridge)

  Ecole Polytechnique Federale de Lausanne· Lausanne, Svájc· EU contribution 3 885 022 EUR· until 2030. dec.· 9 countries

  The disease is named only in the funder's project summary, not in the title.

10 of 4137 running projects, newest first. Listed amounts together: 2,5 Mrd USD + 430,1 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

• Atomoxetine in Melanocortin Obesity Syndrome

  NCT06899178· Icahn School of Medicine at Mount Sinai· Forrás

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 21
• Organoids 10
• Mendelian Randomization Analysis 180
• CRISPR-Cas Systems 7
• Gene Expression Profiling 144
• Sequence Analysis, RNA 10
• Whole Genome Sequencing 4
• Exome Sequencing 19
• Proteomics 127
• Metabolomics 191
• Mass Spectrometry 28
• Flow Cytometry 16
• Immunohistochemistry 41
• Xenograft Model Antitumor Assays 15
• Positron-Emission Tomography 26
• Magnetic Resonance Imaging 258
• Machine Learning 155
• Deep Learning 20
• Cohort Studies 1014
• Genome-Wide Association Study 203

• Fatty acid shifts the cellular composition of small intestinal organoids towards a secretory cell lineage.

  Mol Cell Endocrinol, 2026. szept.

• Omega-3 polyunsaturated fatty acids and epigallocatechin-3-gallate attenuate obesity-associated CD44-high stemness in colorectal cancer through modulation of Notch1, Wnt/β-catenin and PI3K/mTOR signaling.

  Biomed Pharmacother, 2026. szept.

• The generation of brown and white adipose organoids from induced pluripotent stem cells through differentiation into a neuromesodermal stage.

  Life Sci, 2026. jún.

• Hepatoprotective effects of the branched-chain fatty acids 12-methylmyristic and 13-methylmyristic against palmitate-induced lipotoxicity.

  Biomed Pharmacother, 2026. jún.

• Functional human salivary gland organoids for tissue regeneration in chemically defined culture systems.

  Cell Rep Med, 2026. febr.

• A convective transport-enhanced multi-organoid device for therapeutic modeling of the liver-pancreas axis in obesity.

  Theranostics, 2026. jan.

• Adiponectin receptor agonist, AdipoRon, reduces the growth of prostate cancer cells and patient-derived organoids.

  Life Sci, 2025. dec.

• FFAR4 drives stem cell fate toward lipid- and iron-storing enterocytes protecting human enteroids from ferroptosis.

  Stem Cell Res Ther, 2025. dec.

• Patient-derived organoids to study glycosylation dynamics during gastric disease.

  Cell Rep, 2025. nov.

• A saponin from astragalus promotes pancreatic ductal organoids differentiation into insulin-producing cells.

  Phytomedicine, 2022. máj.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.